Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (76)

2023

  1. Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery

    Biology, Vol. 12, Núm. 12

  2. Clinical utility of intraoperative arterial spin labeling for resection control in brain tumor surgery at 3 T

    NMR in Biomedicine, Vol. 36, Núm. 9

  3. Editorial: New insights into the role of neuroinflammation and glial cells in the development of neurological disorders

    Frontiers in Cellular Neuroscience

  4. JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

    ACS Chemical Neuroscience

  5. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2074-2088

  6. Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  7. Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease

    GLIA, Vol. 71, Núm. 3, pp. 571-587

  8. Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning

    Journal of Alzheimer's disease : JAD, Vol. 93, Núm. 1, pp. 125-140

  9. Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models

    Neurobiology of Disease, Vol. 183

  10. Time discrimination and change detection could share a common brain network: findings of a task-based fMRI study

    Frontiers in Psychology, Vol. 14

  11. Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  12. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Brain Metabolic Alterations in Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  2. Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 2, pp. 377-387

  3. Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  4. Grey matter changes on brain MRI in subjective cognitive decline: a systematic review

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1